Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2open access
- Authors
- Kim, R.[Kim, R.]; Kim, C.K.[Kim, C.K.]; Park, J.J.[Park, J.J.]; Kim, J.H.[Kim, J.H.]; Seo, S.I.[Seo, S.I.]; Jeon, S.S.[Jeon, S.S.]; Lee, H.M.[Lee, H.M.]
- Issue Date
- Feb-2019
- Publisher
- KOREAN RADIOLOGICAL SOC
- Keywords
- Outcome; PI-RADS; Prognosis; Prostate cancer; Prostatectomy
- Citation
- KOREAN JOURNAL OF RADIOLOGY, v.20, no.2, pp.256 - 264
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- KOREAN JOURNAL OF RADIOLOGY
- Volume
- 20
- Number
- 2
- Start Page
- 256
- End Page
- 264
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/10996
- DOI
- 10.3348/kjr.2018.0613
- ISSN
- 1229-6929
- Abstract
- Objective: To retrospectively determine whether the use of the Prostate Imaging Reporting and Data System (PI-RADS) version 2 (v2) helps predict long-term outcomes for prostate cancer (PCa) patients following radical prostatectomy (RP). Materials and Methods: A total of 166 patients with localized PCa evaluated with multiparametric magnetic resonance imaging (mpMRI) at 3T before RP were enrolled. Three groups were created based on PI-RADS v2 score used to predict clinical outcomes: group A, >= 3; group B, >= 4; group C, 5. We calculated biochemical recurrence-free survival (RFS) and progression-free survival (PFS). Cox proportion hazards models were used to identify variables predictive of biochemical recurrence and disease progression. Results: During a median follow-up of 9.1 years, biochemical recurrence occurred in 67 patients (40.4%) and disease progression occurred in 55 patients (33.1%). In all groups, 10-year RFS and 10-year PFS were significantly lower for PI-RADS scores >= 3, >= 4 and 5 than for score < 3, < 4 and < 5 (p < 0.05), respectively. In multivariate analysis, PI-RADS score >= 3 and score 5 were significant independent risk marker for biochemical recurrence (hazard ratio [HR] = 5.58, p = 0.018; HR = 1.75, p = 0.033) and disease progression (HR = 3.99, p = 0.047; HR = 2.31, p = 0.040). Moderate inter-observer agreement was seen for PI-RADS scoring. Conclusion: PI-RADS v2 may be used to predict long-term outcomes following RP in PCa.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.